NCT07081360 2025-08-29
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
Minia University
Phase 3 Recruiting
Clinical Trials
15 trialsNCT06868693 2025-03-11
PEACE
Azienda Unita Sanitaria Locale di Piacenza
Not yet recruiting
NCT06630481 2024-10-08
CAP with NAT
Seoul National University Hospital
Completed
NCT06129812 2023-11-13
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Seoul National University Hospital
Completed
NCT00089024 2023-09-29
Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 2 Completed
NCT05399394 2022-06-01
FOLRT
Campus Bio-Medico University
Phase 2 Unknown
NCT02305186 2021-08-13
UVA-PC-PD101
University of Virginia
Phase 1/2 Unknown
NCT01314027 2019-07-25
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
University of Zurich
Phase 3 Terminated
NCT01458717 2018-05-02
Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
Seoul National University Hospital
Phase 2/3 Completed
NCT03469375 2018-03-27
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
NCT00536874 2017-03-16
Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02984501 2016-12-07
Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer
Campus Bio-Medico University
Phase 2 Completed
NCT01521702 2015-03-20
NEOPAC
Institut Paoli-Calmettes
Phase 3 Completed
NCT00524069 2013-02-01
Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
Roswell Park Cancer Institute
Phase NA Withdrawn
NCT00425841 2012-12-12
Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer
Technical University of Munich
Phase 2 Completed